BAYER AG
π©πͺGermany
- Country
- π©πͺGermany
- Ownership
- Public
- Established
- 1863-08-01
- Employees
- 99.7K
- Market Cap
- $30.1B
- Website
- http://www.bayer.com
Evaluating of the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction
- First Posted Date
- 2008-04-21
- Last Posted Date
- 2009-06-22
- Lead Sponsor
- Bayer
- Target Recruit Count
- 102
- Registration Number
- NCT00662441
Open Label Phase II Study of BAY 43-9006 in Chronic Myelogenous Leukemia (CML) Patients Resistant to Gleevec
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-04-18
- Last Posted Date
- 2014-12-23
- Lead Sponsor
- Bayer
- Target Recruit Count
- 10
- Registration Number
- NCT00661180
Depression Related Improvement With Vardenafil for Erectile Response
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-04-18
- Last Posted Date
- 2014-12-23
- Lead Sponsor
- Bayer
- Target Recruit Count
- 280
- Registration Number
- NCT00661219
Assessment of Efficacy of Vardenafil, Influence on Self-esteem and Self-confidence in Subjects With Erectile Dysfunction
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-04-18
- Last Posted Date
- 2014-12-30
- Lead Sponsor
- Bayer
- Target Recruit Count
- 129
- Registration Number
- NCT00661596
Evaluation of Efficacy and Safety of Vardenafil in Patients With Erectile Dysfunction and Type 1 Diabetes
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-04-18
- Last Posted Date
- 2014-12-11
- Lead Sponsor
- Bayer
- Target Recruit Count
- 318
- Registration Number
- NCT00660998
A Double-blind "Preferred" Vardenafil Dose Study of QoL and Functional Outcomes in Males With Erectile Dysfunction
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-04-18
- Last Posted Date
- 2014-11-18
- Lead Sponsor
- Bayer
- Target Recruit Count
- 611
- Registration Number
- NCT00661700
BAY43-9006 Phase II Study for Renal Cell Carcinoma
- First Posted Date
- 2008-04-18
- Last Posted Date
- 2014-12-25
- Lead Sponsor
- Bayer
- Target Recruit Count
- 131
- Registration Number
- NCT00661375
To Investigate the Efficacy and Safety of Vardenafil in Men With Erectile Dysfunction.
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-04-18
- Last Posted Date
- 2014-12-16
- Lead Sponsor
- Bayer
- Target Recruit Count
- 173
- Registration Number
- NCT00661115
Study Evaluating the Efficacy, Safety, and Reliability of Vardenafil
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-04-18
- Last Posted Date
- 2014-12-02
- Lead Sponsor
- Bayer
- Target Recruit Count
- 523
- Registration Number
- NCT00661297
Study to Investigate the Efficacy and Safety of Vardenafil Flexible Dose Versus Placebo in Males With Erectile Dysfunction
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-04-14
- Last Posted Date
- 2013-10-14
- Lead Sponsor
- Bayer
- Target Recruit Count
- 229
- Registration Number
- NCT00657033
Β© Copyright 2024. All Rights Reserved by MedPath